Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation

Timothy A. Hill, Scott G. Stewart, Stephen P. Ackland, Jayne Gilbert, Benjamin Sauer, Jennette A. Sakoff, Adam McCluskey

Research output: Contribution to journalArticlepeer-review

89 Citations (Scopus)

Abstract

A range of amines was reacted with norcantharidin (2) to provide the corresponding norcantharimides (9-43). Treatment of norcantharidin with allylamine afforded the corresponding allyl-norcantharimide (20) which was amenable to epoxidation (mCPBA, 22) and subsequent ring opening (MeOH/H+; 23) or alternatively, osmylation (OSO4/NMO; 24). These simple synthetic modifications of 2 facilitated the development of a novel series of norcantharimides displaying modest to good broad spectrum cytotoxicity against HT29 and SW480 (colorectal carcinoma); MCF-7 (breast adenocarcinoma); A2780 (ovarian carcinoma); H460 (lung carcinoma); A431 (epidermoid carcinoma); DU145 (prostate carcinoma); BE2-C (neuroblastoma); and SJ-G2 (glioblastoma). Analogues possessing a C-10, C-12 or C-14 alkyl chain or a C12 linked bis-norcantharimide displayed the highest levels of cytotoxicity. Crown copyright (c) 2007 Published by Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)6126-6134
Number of pages9
JournalBioorganic & Medicinal Chemistry
Volume15
Issue number18
DOIs
Publication statusPublished - 15 Sep 2007

Fingerprint

Dive into the research topics of 'Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation'. Together they form a unique fingerprint.

Cite this